ECEOX
Price
$10.60
Change
+$0.02 (+0.19%)
Updated
Jan 22 closing price
Net Assets
113.96M
VEMIX
Price
$27.97
Change
+$0.05 (+0.18%)
Updated
Jan 22 closing price
Net Assets
108.96B
Ad is loading...

ECEOX vs VEMIX

Header iconECEOX vs VEMIX Comparison
Open Charts ECEOX vs VEMIXBanner chart's image
Lazard Emerging Markets Core Equity Open
Price$10.60
Change+$0.02 (+0.19%)
VolumeN/A
Net Assets113.96M
Vanguard Emerging Mkts Stock Idx Instl
Price$27.97
Change+$0.05 (+0.18%)
VolumeN/A
Net Assets108.96B
ECEOX vs VEMIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ECEOX vs. VEMIX commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ECEOX is a Hold and VEMIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEMIX has more cash in the bank: 109B vs. ECEOX (114M). VEMIX pays higher dividends than ECEOX: VEMIX (3.46) vs ECEOX (1.22). ECEOX was incepted earlier than VEMIX: ECEOX (11 years) vs VEMIX (25 years). ECEOX is a more actively managed with annual turnover of: 74.00 vs. VEMIX (5.00). ECEOX has a lower initial minimum investment than VEMIX: ECEOX (2500) vs VEMIX (5000000). VEMIX (14.92) and ECEOX (14.56) have marching annual gain over last year. VEMIX return over 5 years is better than : 9.12 vs. ECEOX (-5.79).
ECEOXVEMIXECEOX / VEMIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years25 years-
Gain YTD2.124-0.143-1,484%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets114M109B0%
Annual Yield % from dividends1.223.4635%
Returns for 1 year14.5614.9298%
Returns for 3 years-3.66-4.0690%
Returns for 5 years-5.799.12-63%
Returns for 10 years12.3226.2147%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAH142.456.39
+4.70%
Booz Allen Hamilton Holding Corp
CARM0.460.02
+4.38%
Carisma Therapeutics
ABCL3.060.09
+3.03%
AbCellera Biologics
DXLG2.820.06
+2.17%
Destination XL Group
PYCR22.120.02
+0.09%
Paycor HCM